269 related articles for article (PubMed ID: 32323846)
21. LMO4 is an essential mediator of ErbB2/HER2/Neu-induced breast cancer cell cycle progression.
Montañez-Wiscovich ME; Seachrist DD; Landis MD; Visvader J; Andersen B; Keri RA
Oncogene; 2009 Oct; 28(41):3608-18. PubMed ID: 19648968
[TBL] [Abstract][Full Text] [Related]
22. Long non-coding RNA SNHG1 regulates NOB1 expression by sponging miR-326 and promotes tumorigenesis in osteosarcoma.
Wang J; Cao L; Wu J; Wang Q
Int J Oncol; 2018 Jan; 52(1):77-88. PubMed ID: 29115574
[TBL] [Abstract][Full Text] [Related]
23. LncRNA SNHG1 promotes cell progression and metastasis via sponging miR-377-3p in hepatocellular carcinoma.
Qu A; Yang Q
Neoplasma; 2020 May; 67(3):557-566. PubMed ID: 32122143
[TBL] [Abstract][Full Text] [Related]
24. lncRNA SNHG1 negatively regulates miRNA‑101‑3p to enhance the expression of ROCK1 and promote cell proliferation, migration and invasion in osteosarcoma.
Deng R; Zhang J; Chen J
Int J Mol Med; 2019 Mar; 43(3):1157-1166. PubMed ID: 30592267
[TBL] [Abstract][Full Text] [Related]
25. LncRNA SNHG1 regulates the differentiation of Treg cells and affects the immune escape of breast cancer via regulating miR-448/IDO.
Pei X; Wang X; Li H
Int J Biol Macromol; 2018 Oct; 118(Pt A):24-30. PubMed ID: 29886172
[TBL] [Abstract][Full Text] [Related]
26. Increased long noncoding RNA LASP1-AS is critical for hepatocellular carcinoma tumorigenesis via upregulating LASP1.
Yin L; Chen Y; Zhou Y; Deng G; Han Y; Guo C; Li Y; Zeng S; Shen H
J Cell Physiol; 2019 Aug; 234(8):13493-13509. PubMed ID: 30677131
[TBL] [Abstract][Full Text] [Related]
27. lnc‑MICAL2‑1 sponges miR‑25 to regulate DKK3 expression and inhibits activation of the Wnt/β‑catenin signaling pathway in breast cancer.
Yao J; Li G; Liu M; Yang S; Su H; Ye C
Int J Mol Med; 2022 Feb; 49(2):. PubMed ID: 34970696
[TBL] [Abstract][Full Text] [Related]
28. Circular RNA circBACH2 plays a role in papillary thyroid carcinoma by sponging miR-139-5p and regulating LMO4 expression.
Cai X; Zhao Z; Dong J; Lv Q; Yun B; Liu J; Shen Y; Kang J; Li J
Cell Death Dis; 2019 Feb; 10(3):184. PubMed ID: 30796202
[TBL] [Abstract][Full Text] [Related]
29. The Interaction Between lncRNA SNHG1 and miR-140 in Regulating Growth and Tumorigenesis via the TLR4/NF-κB Pathway in Cholangiocarcinoma.
Li Z; Li X; Du X; Zhang H; Wu Z; Ren K; Han X
Oncol Res; 2019 Jun; 27(6):663-672. PubMed ID: 30764893
[TBL] [Abstract][Full Text] [Related]
30. LncRNA SNHG1 promoted HGC-27 cell growth and migration via the miR-140/ADAM10 axis.
Guo W; Huang J; Lei P; Guo L; Li X
Int J Biol Macromol; 2019 Feb; 122():817-823. PubMed ID: 30391432
[TBL] [Abstract][Full Text] [Related]
31. Long non-coding RNA LINC01207 promotes prostate cancer progression by downregulating microRNA-1972 and upregulating LIM and SH3 protein 1.
Wang S; Qiu J; Wang L; Wu Z; Zhang X; Li Q; Jiang F
IUBMB Life; 2020 Sep; 72(9):1960-1975. PubMed ID: 32726517
[TBL] [Abstract][Full Text] [Related]
32. Up-regulated lnc-SNHG1 contributes to osteosarcoma progression through sequestration of miR-577 and activation of WNT2B/Wnt/β-catenin pathway.
Jiang Z; Jiang C; Fang J
Biochem Biophys Res Commun; 2018 Jan; 495(1):238-245. PubMed ID: 29108989
[TBL] [Abstract][Full Text] [Related]
33. LIM-Only Protein 4 (LMO4) and LIM Domain Binding Protein 1 (LDB1) Promote Growth and Metastasis of Human Head and Neck Cancer (LMO4 and LDB1 in Head and Neck Cancer).
Simonik EA; Cai Y; Kimmelshue KN; Brantley-Sieders DM; Loomans HA; Andl CD; Westlake GM; Youngblood VM; Chen J; Yarbrough WG; Brown BT; Nagarajan L; Brandt SJ
PLoS One; 2016; 11(10):e0164804. PubMed ID: 27780223
[TBL] [Abstract][Full Text] [Related]
34. Long noncoding RNA SNHG1 promotes human prostate cancer progression by sponging miR-383-5p.
Huang G; Guo X; Yang H
Anticancer Drugs; 2021 Mar; 32(3):286-295. PubMed ID: 33470616
[TBL] [Abstract][Full Text] [Related]
35. Long non-coding RNA SNHG1 contributes to cisplatin resistance in non-small cell lung cancer by regulating miR-140-5p/Wnt/β-catenin pathway.
Shi SL; Zhang ZH
Neoplasma; 2019 Sep; 66(5):756-765. PubMed ID: 31288529
[TBL] [Abstract][Full Text] [Related]
36. LncRNA SNHG1 promotes cell proliferation in laryngeal cancer via Notch1 signaling pathway.
Liu T; Zuo JJ; Li F; Xu YC; Zheng AY; Tao ZZ
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6562-6569. PubMed ID: 31378897
[TBL] [Abstract][Full Text] [Related]
37. Long noncoding RNA SNHG1 predicts a poor prognosis and promotes hepatocellular carcinoma tumorigenesis.
Zhang M; Wang W; Li T; Yu X; Zhu Y; Ding F; Li D; Yang T
Biomed Pharmacother; 2016 May; 80():73-79. PubMed ID: 27133041
[TBL] [Abstract][Full Text] [Related]
38. LncRNA SNHG1 contributes to the regulation of acute myeloid leukemia cell growth by modulating miR-489-3p/SOX12/Wnt/β-catenin signaling.
Li C; Gao Q; Wang M; Xin H
J Cell Physiol; 2021 Jan; 236(1):653-663. PubMed ID: 32592199
[TBL] [Abstract][Full Text] [Related]
39. Long non-coding RNA SNHG1 functions as a competitive endogenous RNA to regulate PDCD4 expression by sponging miR-195-5p in hepatocellular carcinoma.
Huang D; Wei Y; Zhu J; Wang F
Gene; 2019 Sep; 714():143994. PubMed ID: 31330233
[TBL] [Abstract][Full Text] [Related]
40. The long non-coding RNA SNHG1 promotes bladder cancer progression by interacting with miR-143-3p and EZH2.
Xiang W; Lyu L; Huang T; Zheng F; Yuan J; Zhang C; Jiang G
J Cell Mol Med; 2020 Oct; 24(20):11858-11873. PubMed ID: 32885590
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]